C-reactive Protein and Endothelial Dysfunction in Women With Glucose Intolerance

Completed

Conditions studied: Glucose Intolerance

In brief

The goal of this study is to determine whether markers of vascular inflammation (such as c-reactive protein) can predict endothelial dysfunction (as measured by flow-mediated dilation) in postmenopausal women with glucose intolerance compared to normal controls.

Key facts

Study ID

NCT00589355

Run by

Yale University

People needed

46

Starts

2002-01-01

Expected to finish

2008-10-01

Last updated by the study team

2020-04-17

Who can join

Age: 40 and older, up to 65. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• healthy postmenopausal women
• ages 40-65

You may not qualify if…

• smokers
• diabetes requiring medication

Where it is running

• Yale Center for Clinical Investigation — New Haven, Connecticut, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.